199 results match your criteria: "Surgical-Medical Research Institute[Affiliation]"
Biol Direct
April 2007
Department of Surgery, Surgical-Medical Research Institute, University of Alberta, Edmonton, Alberta, Canada.
Background: Transplant rejection has been considered to occur primarily because donor antigens are not present during the development of the recipient's immune system to induce tolerance. Thus, transplantation prior to recipient immune system development (pre-immunocompetence transplants) should induce natural tolerance to the donor. Surprisingly, tolerance was often not the outcome in such 'natural tolerance models'.
View Article and Find Full Text PDFEur J Immunol
May 2007
Department of Surgery, Surgical-Medical Research Institute, University of Alberta, Edmonton, Canada.
Stable mixed chimerism has been considered the most robust tolerance strategy. However, rejection of solid donor tissues by chimeras has been observed, a state termed split tolerance. Since new non-myeloablative mixed chimerism approaches are being actively pursued, we sought to determine whether they lead to full tolerance or split tolerance and to define the mechanisms involved.
View Article and Find Full Text PDFJ Endocrinol
October 2006
Department of Surgery, Surgical-Medical Research Institute, 1074 Dentistry Pharmacy Center, University of Alberta, Alberta, Edmonton, Canada.
Prolonged exposure to high glucose can influence the function, growth, and survival of pancreatic beta-cells. In this study, we examine the effects of prolonged in vitro exposure to high glucose on neonatal porcine beta-cells, a potentially useful source of insulin-producing cells for clinical islet transplantation. Neonatal porcine islets were prepared by culturing collagenase-digested pancreases for 1 week in 5.
View Article and Find Full Text PDFXenotransplantation
November 2006
Department of Surgery, Dentistry Pharmacy Centre, Surgical-Medical Research Institute, University of Alberta, Edmonton, AB, Canada.
Background: The immune mechanisms associated with the rejection of microencapsulated neonatal porcine islets (NPI) are not clearly understood. Therefore, in this study we characterized the immune cells and molecules that are involved in this process by examining the microencapsulated NPI xenografts at various time points post-transplantation in B6 mice.
Methods: Microencapsulated NPI were transplanted into streptozotocin-induced diabetic immune-competent B6 and immune-deficient B6 rag-/- mice and blood glucose levels were monitored twice a week.
Diabetologia
October 2006
Surgical-Medical Research Institute, 1074 Dentistry/Pharmacy Centre, University of Alberta, Edmonton, AB, Canada.
Aims/hypothesis: The Edmonton Protocol for islet transplantation has provided hope for type 1 diabetic patients. However, this protocol requires lifelong immunosuppression, specifically sirolimus, a cellular antiproliferate. The effect of sirolimus on human pancreatic ductal cells (HDCs) is not known.
View Article and Find Full Text PDFDiabetes
July 2006
Surgical Medical Research Institute, University of Alberta, Edmonton, AB T6G 2N8.
A substantial proportion of the transplanted islet mass fails to engraft due to death by apoptosis, and a number of strategies have been explored to inhibit beta-cell loss. Inhibition of extrinsic signals of apoptosis (i.e.
View Article and Find Full Text PDFDiabetologia
August 2006
Department of Surgery, Surgical-Medical Research Institute, 1074 Dentistry Pharmacy Center, University of Alberta, Edmonton, Alberta T6G 2N8, Canada.
Aims/hypothesis: Neurogenin 3 (NEUROG3), a basic helix-loop-helix transcription factor that is needed for endocrine cell development in the embryonic pancreas, has been shown to induce transdifferentiation of duct cells from adult pancreas towards a neuro-endocrine phenotype. Our study explored the endocrine transdifferentiation potential of NEUROG3 in neonatal pancreatic precursor cells.
Materials And Methods: A replication-deficient adenovirus expressing Neurog3 and green fluorescent protein (GFP) (Ad-NEUROG3) was used to infect neonatal pig pancreatic cell preparations enriched for endocrine islet and cytokeratin-positive precursor cells.
Cell Transplant
June 2006
Surgical-Medical Research Institute, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.
This study assessed the effects of a two-layer method (TLM), using perfluorocarbon and UW solution, on the quality of human pancreata following storage and islet yield/function after isolation. In part A, TLM was applied immediately after procurement and the energetic profile was compared to a group treated with UW solution only (control) throughout 24-h storage. In part B, cadaveric human pancreata were procured and subjected to a TLM after cold storage in UW solution (TLM group) or UW solution (control group).
View Article and Find Full Text PDFScand J Immunol
April 2006
Department of Surgery, Surgical-Medical Research Institute, University of Alberta, Edmonton, Alberta, Canada T6G 2N8.
In Credo 2004, Zinkernagel and Hengartner (Z&H) have continued their challenge to the immunological community to reconsider assumptions regarding the most fundamental aspects of adaptive immunity. They have appropriately championed the role of persistent, widely distributed antigen in tolerance induction, parameters that do not figure prominently in most other models. The global theory of immunity they have developed is predominantly based on observations from studies with viruses and tumours.
View Article and Find Full Text PDFSurgery
March 2006
Surgical-Medical Research Institute, 1074 Dentistry-Pharmacy Building, University of Alberta, Edmonton, Alberta, Canada T6G 2N8.
Background: Oxidative stress during cold small bowel (SB) storage has not been investigated because oxygen is depleted rapidly after procurement. We hypothesized that oxidative catabolism facilitated by a proven amino acid-based (AA) storage solution promotes oxidative stress; furthermore, there is an important role for antioxidant supplementation during cold storage.
Methods: SB from Sprague-Dawley rats (n = 6 in each group) were procured according to standardized procedures involving vascular flush with modified University of Wisconsin solution and luminal treatment with an AA-based solution proven previously to aid preservation.
Lab Invest
February 2006
Surgical-Medical Research Institute, University of Alberta, Edmonton, AB, Canada.
Fibroblast-like cells emerging from cultured human pancreatic endocrine and exocrine tissue have been reported. Although a thorough phenotypic characterization of these cells has not yet been carried out, these cells have been hypothesized to be contaminating fibroblasts, mesenchyme and/or possibly beta-cell progenitors. In this study, we expanded fibroblast-like cells from adult human exocrine pancreas following islet isolation and characterized these cells as mesenchymal stem cells (MSCs) based on their cell surface antigen expression and ability to differentiate into mesoderm.
View Article and Find Full Text PDFTransplantation
November 2005
Surgical-Medical Research Institute, University of Alberta, and Department of Laboratory Medicine and Pathology, Division of Anatomical Pathology, University of Alberta Hospital, Edmonton, Canada.
Background: This study tested the effectiveness of a nutrient-rich preservation solution in a small animal model of orthotopic whole small bowel transplantation.
Methods: Lewis rats received syngeneic total orthotopic small bowel graft after cold storage for 6 h. Donor small bowel was flushed vascularly with University of Wisconsin (UW) solution and flushed luminally with UW solution or an amino acid-rich (AA) solution as follows: Group 1, no luminal flush; Group 2, UW solution; Group 3, AA solution.
Tissue Eng
December 2005
Surgical-Medical Research Institute, University of Alberta, Edmonton, AB, Canada.
Clinical islet transplantation in liver has achieved normoglycemia. However, this site may not be ideal for islet survival. To create a more optimal site for islet transplantation, we have developed a construct with biodegradable scaffolds.
View Article and Find Full Text PDFTransplantation
September 2005
Surgical-Medical Research Institute, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.
Background: The aim of this study was to determine whether short-term administration of a combination of anti-CD154 and anti-LFA-1 monoclonal antibodies can prolong the survival of microencapsulated neonatal porcine islets (NPI) in immunocompetent mice.
Methods: Microencapsulated NPI were transplanted into the peritoneal cavity of streptozotocin-induced diabetic B6 mice that received a short-term treatment of a combination of anti-CD154 and anti-LFA-1 monoclonal antibodies. Blood glucose levels of each recipient were measured for more than 100 days posttransplantation or until graft rejection.
Transplantation
September 2005
Human Islet Investigations Laboratory, Surgical Medical Research Institute, University of Alberta, Edmonton, Alberta, Canada.
Background: The variability in collagenase blends has been speculated as the single most important determinant of the success or failure in isolated islet yields in clinical islet transplantation. Examination of the formulation and potency of the widely used Liberase HI enzyme blend will uncover possible sources of imprecision.
Methods: High performance liquid chromatography (HPLC) and kinetic measurements of collagenase and protease activity were used to assess potency.
Transplantation
August 2005
Surgical Medical Research Institute, Department of Surgery, University of Alberta, Canada.
Background: Whether mixed chimeras induced by nonmyeloablative conditioning are tolerant to challenge with donor allogeneic islet grafts is unknown. Here we investigate whether our nonmyeloablative, costimulation blockade-free and sirolimus (SRL)-based protocol could facilitate mixed chimerism via bone marrow transplantation (BMT) and induce islet allograft tolerance.
Methods: After low dose (1-3 Gy) total body irradiation (TBI, day -1), with or without prior lymphocyte depletion, C57BL/6 mice were transfused with 40 x 10(6) BALB/c bone marrow cells (day 0) and received SRL (3 mg/kg/day) for 4 weeks.
Am J Respir Crit Care Med
September 2005
Department of Pediatrics, Division of Neonatology, Surgical-Medical Research Institute, University of Alberta, Edmonton, Alberta, Canada.
Rationale: Bronchopulmonary dysplasia (BPD), the chronic lung disease of preterm infants, and pulmonary emphysema, both significant global health problems, are characterized by an arrest in alveolar growth/loss of alveoli structures. Mechanisms that inhibit distal lung growth are poorly understood, but recent studies suggest that impaired vascular endothelial growth factor signaling and reduced nitric oxide (NO) production decreases alveolar and vessel growth in the developing lung, features observed in experimental oxygen-induced BPD. NO exerts its biological activity by stimulating guanosine 3',5'-cyclic monophosphate (cGMP) production.
View Article and Find Full Text PDFTransplant Proc
March 2005
Department of Surgery Surgical-Medical Research Institute, University of Alberta, Edmonton, Alberta, Canada.
Introduction: Islet transplantation has proven to be a successful treatment for insulin-dependent diabetes mellitus (IDDM). The aim of this study was to establish an algorithm by which the combination of the donor quality and pancreas quality was given a numerical score from 0 to 100 for use in determining the quality of a pancreas for islet isolation.
Methods: In this study we retrospectively analyzed 326 pancreata and the outcomes of their respective isolations.
Cryobiology
February 2005
Surgical-Medical Research Institute, 1074 Dentistry-Pharmacy Building, University of Alberta, Edmonton, Alta., Canada T6G 2N8.
Introduction: Donor nutritional status may be a determinant of small bowel (SB) quality following storage. In this study, we investigated the effect of donor nutritional status and a proven nutrient-rich preservation solution on graft quality following cold storage.
Methods: Rats were fasted (12-14 h) or non-fasted.
Diabetes
February 2005
Surgical-Medical Research Institute, University of Alberta, Edmonton, Canada.
A variety of transient therapies directed against molecules involved in T-cell activation and function result in long-term islet allograft survival. However, there are relatively few examples of durable islet xenograft survival using similar short-term approaches, especially regarding highly phylogenetically disparate xenograft donors. Previous studies demonstrate that combined anti-lymphocyte function-associated antigen-1 (LFA-1) plus anti-CD154 therapy results in a robust form of islet allograft tolerance not observed with either individual monotherapy.
View Article and Find Full Text PDFBiol Reprod
May 2005
Surgical-Medical Research Institute, University of Alberta, Edmonton, Alberta, Canada.
Sertoli cells protect cotransplanted cells from allogeneic and xenogeneic rejection. Additionally, neonatal porcine Sertoli cells (NPSCs) survive long-term as xenografts in nonimmunosuppressed rodents. This has led to the hypothesis that NPSCs could be used to prevent cellular rejection in clinical transplantation, thereby eliminating the need for chronic immunosuppression.
View Article and Find Full Text PDFDiabetes
December 2004
Surgical Medical Research Institute, University of Alberta, Edmonton, Canada.
The success of the Edmonton Protocol for islet transplantation has provided new hope in the treatment of type 1 diabetes. This study reports on the assessment of 83 human islet grafts transplanted using the Edmonton Protocol since 1999. Cellular composition, as assessed by immunohistochemistry, showed a lower islet purity (approximately 40%) than has been reported in previous studies using dithizone staining to quantitate islet equivalents.
View Article and Find Full Text PDFDiabetologia
October 2004
Surgical-Medical Research Institute, Dentistry/Pharmacy Building, University of Alberta, Edmonton, Alberta, Canada.
Aims/hypothesis: The aim of this study was to determine whether a simple alginate capsule can prolong islet survival and function during long-term tissue culture. We also wanted to observe the ability of these encapsulated islets to restore glucose responsiveness to diabetic recipients, along with the quantity of islets required to do so.
Methods: We compared the recovery and metabolic function of encapsulated canine islets with that of non-encapsulated canine islets following 1, 2 or 3 weeks of tissue culture.
Pancreas
October 2004
Surgical-Medical Research Institute, University of Alberta, Edmonton, Alberta, Canada.
Objectives: The purpose of this study was to evaluate the functional significance of the renal capsular vessels in renal subcapsular islet grafts.
Methods: Syngeneic islets were transplanted under the left renal capsule of diabetic Wistar-Furth rats. At 4 weeks post-transplantation, the left renal artery and vein were ligated (group A); in group B, the left renal capsule was dissected to remove capsular vessels; or both were performed in group C.
Front Biosci
September 2004
Department of Surgery, Surgical-Medical Research Institute, 1074 Dentistry/Pharmacy Centre, University of Alberta, Edmonton, Alberta, Canada T6G 2N8.
Each response made by our immune system is either to promote or to prevent immune reactivity. That the immune system can successfully achieve both goals under specific biological conditions depends on central and peripheral tolerance mechanisms. Over the years, various experimental systems have been generated to study peripheral CD4 T cell tolerance.
View Article and Find Full Text PDF